Stay updated on Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.

Latest updates to the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedFooter revision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedPublications section now states that entries are automatically filled from PubMed and may not be about the study, replacing the previous wording. The revision is updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check32 days agoChange DetectedRemoved the funding-status notice from the page, which previously warned that government funding could affect data currency and response times. The core study details, contacts, and locations are unaffected by this deletion. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedNo significant additions or deletions were detected between the two screenshots; the study details, eligibility criteria, and locations list remained unchanged.SummaryDifference0.2%

- Check75 days agoChange DetectedCore content updated to include government operating status notice and new version v3.2.0; prior version v3.0.2 removed.SummaryDifference1%

- Check76 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content.SummaryDifference0.0%

Stay in the know with updates to Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.